Article Versions Notes

Souza JDR, Pacheco JC, Rossi GN, de-Paulo BO, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA, Dos Santos RG. Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022). Pharmaceutics. 2022; 14(12):2598. https://doi.org/10.3390/pharmaceutics14122598

Souza, José Diogo R., Julia Cozar Pacheco, Giordano Novak Rossi, Bruno O. de-Paulo, Antonio W. Zuardi, Francisco S. Guimarães, Jaime E. C. Hallak, José Alexandre Crippa, and Rafael G. Dos Santos. 2022. "Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)" Pharmaceutics 14, no. 12: 2598. https://doi.org/10.3390/pharmaceutics14122598

Souza, J. D. R., Pacheco, J. C., Rossi, G. N., de-Paulo, B. O., Zuardi, A. W., Guimarães, F. S., Hallak, J. E. C., Crippa, J. A., & Dos Santos, R. G. (2022). Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022). Pharmaceutics, 14(12), 2598. https://doi.org/10.3390/pharmaceutics14122598